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ABSTRACT Results of thaw-mount autoradiographic
studies of kidney obtained 1-3 hr after a single injection of
1,25-0H)243Hjvitamin D3 to rats showed strong nuclear con-
centration of radioactivity in podocytes and cells of distal tu-
bules, including the pars convoluta, macula densa, and pars
recta. Intermediate nuclear concentration was found in cells
of the thin limb of Henle's loops, whereas weak or no nuclear
uptake was seen in cells of the proximal tubules. In contrast,
after injection of 3H-labeled parathyroid hormone or [3H1es-
tradiol, mainly cells of the proximal tubules were labeled; after
3H-labeled parathyroid hormone, apical cytoplasmic uptake of
radioactivity was seen most strongly in the proximal part of the
proximal tubules, whereas, after [3Hlestradiol, weak nuclear
concentration was seen in cells throughout the proximal tubules.
The results are consistent with the concept that synthesis of
1,25-0Hh2-vitamin D3 occurs in the proximal tubules under
stimulation of parathyroid hormone or estradiol (or other hor-
mones) and that the major site of action of 1,25(0H)2-vitamin
D3 is in the distal tubules.
It is generally accepted that the kidney is both the site of syn-
thesis of 1,25-(OH)2-vitamin D3 and one of its target organs (see
review 1). On the basis of clinical, physiological, and bio-
chemical studies, both the proximal and distal portions of the
nephrons have been suggested as the possible sites of synthesis
or the target tissues for the hormone (1, 2). However, no precise
localization has so far been accomplished.
The use of thaw-mount autoradiography has greatly helped
to identify target cells for steroid hormones and has provided
preliminary evidence for the localization of 1,25-(OH)2-vitamin
D3 in the kidney (3). The present study seeks to define the an-
atomical distribution of the labeled hormone at the cellular and
subcellular levels.
In addition, a comparative autoradiographic study of the
localization of parathyroid hormone and estrogen is also con-
ducted. Because it is believed that these hormones regulate the
synthesis of 1,25-(OH)2-vitamin D3 (1), it is expected that their
localization should aid in the identification of the sites of pro-
duction of 1,25-(OH)2-vitamin D3.
MATERIALS AND METHODS
1,25-(0H)2gVitamin D3. Six male Sprague-Dawley rats,
weighing 190-200 g, were placed on a vitamin D-deficient diet
for 35 days, supplemented with vitamins A, E, and K (4). Each
animal was injected intravenously, four animals with 0.16
,g/100 g of body weight (specific activity 160 Ci/mmol; 1 Ci
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= 3.7 X 1010 becquerels) and two animals with 0.19 Mtg/100 g
of body weight (specific activity 90 Ci/mmol) of 1,25-
(OH)2-[26,27-3H]vitamin D3, dissolved in 75% (vol/vol) etha-
nol/isotonic saline. The animals of the former group were
sacrificed 2 hr and those of the latter group 1 or 3 hr after the
injection. Two of the rats that received the low dose (0.16
Mg/100 g of body weight) were each injected subcutaneously
with 1.0 Mig of 1,25-(OH)2-vitamin D3 15 min prior to the in-
jection of 1,25-(OH)2-[3H]vitamin D3.
Estradiol-17#t. Five male and five female Sprague-Dawley
rats, weighing 210-230 g and gonadectomized for 18 days, were
injected intravenously each with 0.1 Mug/100 g of body weight
of [2,4,6,7-3H]estradiol-17f3 (specific activity 100 Ci/mmol),
dissolved in 75% ethanol/isotonic saline. The animals were
sacrificed 1 hr afterwards.
Parathyroid Hormone. Eight male Sprague-Dawley rats,
weighing 150-180 g, were thyroid-parathyroidectomized and
placed on a low-calcium diet for 5 days. Each animal was in-
jected intravenously, two with 3.4 Mug/100 g of body weight and
six with 0.064 Mug/100 g of body weight of 3H-labeled para-
thyroid hormone [supplied by J. E. Zull and prepared according
to Zull et al. (5); specific activity 16 Ci/mmol] dissolved in 75%
ethanol/isotonic saline. The animals were sacrificed 5 and 10
min after the injection. Three of the low-dose rats were each
injected intravenously with 10 Mug of unlabeled parathyroid
hormone together with 3H-labeled parathyroid hormone, in
order to establish specificity of the label.
In the experiments with 1,25-(OH)2-[3H]vitamin D3 and
[3H]estradiol, the animals were decapitated, and tissues were
excised, placed on tissue holders, and frozen in liquefied pro-
pane at -180°C. Sections (4-,um) were cut in a Harris WR
cryostat (Harris, North Billerica, MA) at -35'C, under safety
lights, and thaw-mounted on slides coated with photographic
emulsion (Kodak NTB3). The sections mounted on the slides
were exposed at -15°C for 7-24 months in lightproof desiccator
boxes. At the end of exposure, the slides were photographically
processed and stained with methyl green pyronin or methylene
blue/basic fuchsin. Positive chemographic artifacts were ex-
cluded by control autoradiograms of the same tissues without
injection of radioactively labeled material. Because extended
exposure times increased silver grain yield, loss of sensitivity
or latent image fading is unlikely or low. The thaw-mount au-
toradiographic technique (6) has been described in detail (7).
Cells are considered as labeled if the nuclear accumulation of
silver grains exceeds the number of silver grains in the cyto-
plasm.
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FIG 1. Thaw-mount autoradiograms of rat kidney 2 hr after injection of 1,25-(OH)2-[26,27-3H]vitamin D3 (0.16 ,gg/100 g of body weight),
showing nuclear concentration of radioactivity in epithelial cells of distal convoluted tubules (dt), including the macula densa (md) (A), and
in podocytes in glomerulus (gl) (A and B). Nuclei of epithelial cells of proximal tubules (pt) (A-C) show no or only a little uptake of radioactivity.
(C) Cells with nuclear labeling in the pars recta of distal tubules and unlabeled proximal tubules in the inner cortex. In the outer medulla (D)
of another animal, a weak nuclear labeling can be seen in epithelial cells of the pars recta of proximal tubules, whereas cells of the pars recta
of distal tubules (thick limb of Henle's loop) show distinct nuclear labeling. Epithelial cells of the thin limb of Henle's loop (hl) also show nuclear
concentration of radioactivity (E). Nuclear concentration of radioactivity in distal convoluted tubules is reduced when unlabeled 1,25-(OH)2-
vitamin D3 is preinjected (F). (Exposure time 7 months for A and C-F or 9 months for B. X600 for A and C-F; X900 for B. Stained with methylene
blue/basic fuchsin.)
For the localization of [3H]parathyroid hormone, the kidney
was sliced into small pieces and fixed in 2% (wt/vol) glutaral-
dehyde in 0.1 M sodium phosphate buffer, and the tissues were
dehydrated through alcohol and acetone and embedded in
Epon 812. Sections (1-2,tm) were cut, mounted on slides, and
dipped in Kodak NTB3 emulsion. The slides were stored in
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FIG. 2. Schematic representation of a kidney nephron, showing
the distribution of 1,25-(OH)2-vitamin D3 target cells. Occurrence
of cells with the strongest nuclear concentration is indicated in black:
distal tubule with macula densa, its pars recta (thick portion of
Henle's loop) and pars convoluta; and podocytes in glomerulus. In-
termediate intensity of nuclear labeling in thin limb of Henle's loop
and low intensity of nuclear labeling in proximal tubule is indicated
by low density of black dots.
lightproof desiccator boxes and exposed at -15'C. After 3-12
months, the slides were photographically developed, fixed, and
stained with toluidine blue.
RESULTS
After injection of 1,25-(OH)2-[3H]vitamin D3, in all animals
studied, nuclear concentration and retention of radioactivity
was observed in certain cells in the kidney. In the glomerulus,
radioactivity was concentrated in cells of the inner layer of
Bowman's capsule and in podocytes (Fig. 1 A and B), whereas
inner and outer mesangial cells, as well as endothelial cells,
appeared to be unlabeled. Podocytes were identified by their
position, shape, and staining properties, which allow one to
distinguish them, although not with certainty, from mesangial
cells. Nuclear concentration of radioactivity was pronounced
in epithelial cells of the distal tubule, including the pars con-
voluta and macula densa (Fig. 1A) and the pars recta (Fig. 1
C and D). Weak, although distinct, nuclear labeling was seen
in cells of the thin limb of Henle's loop (Fig. 1E). Depending
on dose and exposure time, nuclear concentration of radioac-
tivity, although relatively weak, could be recognized in cells
throughout the proximal tubule, especially its pars recta (Fig.
1D). At certain exposure times the proximal tubule was unla-
beled, whereas in the distal tubule distinct nuclear labeling was
present (Fig. 1 A and C). In epithelial cells of the collecting
duct, no nuclear concentration of radioactivity was seen under
the conditions of the experiments. Injection of 1,25-(OH)2-
vitamin D3 prior to 1,25-(OH)2-[3H]vitamin D3 reduced nuclear
concentration of radioactivity (Fig. IF). Fig. 2 schematically
summarizes the distribution of 1,25-(OH)2-vitamin D3 target
cells in a kidney nephron.
After injection of 3H-labeled estradiol, nuclear concentration
of radioactivity was found in interstitial cells located between
tubules and at glomeruli [not shown here; see Stumpf and Sar
(8)] and in epithelial cells of proximal tubules (Fig. 3 A and B),
whereas epithelial cells of distal tubules and maculae densae
appeared unlabeled. The nuclear concentration of radioactivity
in proximal tubules was relatively weak, when compared to the
uterus.
After injection of 3H-labeled parathyroid hormone, radio-
activity was concentrated in the proximal portion of these tu-
bules (Fig. 4), with declining concentration toward the distal
portion of the proximal tubules. Epithelial cells of distal con-
voluted tubules, of collecting ducts, and of the glomeruli are
unlabeled under the conditions of the experiment.
DISCUSSION
The present autoradiographic studies with 1,25-(OH)2-vitamin
D3 show concentration and retention of radioactivity in nuclei
of certain cell types, as is characteristic for target cells for steroid
hormones (8, 9). The radioactivity detected in cell nuclei after
the injection of 1,25-(OH)2-[3H]vitamin D3 probably represents
the parent compound or its metabolite(s), because preinjection
of the unlabeled hormone diminishes nuclear uptake and be-
cause some of the target sites found coincide with postulated
sites of action of this hormone.
While a large part of the calcium contained in the glomerular
ultrafiltrate is resorbed at the level of the proximal convoluted
tubule, it is the distal part of the nephron where a differential
resorption takes place. Both sodium and calcium ions are se-
lectively resorbed by the distal tubule (10). It has been proposed
that it is in the distal part of the nephron that 1,25-(OH)2-vi-
tamin D3 is capable of acting to influence the resorption of
calcium (1). In support of this concept, vitamin D-dependent
calcium-binding protein has been localized immunohisto-
chemically in distal tubules of avian and mammalian kidneys
(11). The concentration of 1,25-(OH)2-vitamin D3 in distal
tubules presently demonstrated provides evidence for the
proposed site of action of 1,25-(OH)2-vitamin D3.
The localization of 1,25-(OH)2-vitamin D3 in the nuclei of
macula densa cells, which are part of the juxtaglomerular ap-
paratus, is noteworthy. This apparatus is concerned with the
hormonal regulation of sodium absorption (12). Because cal-
cium is resorbed following the same pattern as sodium (10), it
is possible that the localization of 1,25-(OH)2-vitamin D3 at this
site indicates involvement of the macula densa in hormonal
calcium regulation.
A possible action of vitamin D and its metabolites on phos-
phate absorption by the kidney has been repeatedly discussed.
Harrison and Harrison (13) showed that vitamin D inhibits
phosphate resorption. This action was later explained as an
indirect effect that results from secondary hyperparathyroidism
(14). Phosphate resorption occurs mainly through the proximal
convoluted tubule and is regulated primarily by parathyroid
hormone (10). 1,25-(OH)2-vitamin D3 is capable of producing
phosphaturia, but only when hyperphosphatemia is previously
present (15). It is presently believed that 1,25-(OH)2-vitamin
D3 plays only a permissive role on the phosphate resorption
induced by parathyroid hormone (1). It is possible that the weak
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FIG. 3. Thaw-mount autoradiograms of rat kidney 1 hr after injection of [3H]estradiol-17f3, showing weak nuclear concentration of radioactivity
in cells of proximal tubules (pt) (A), whereas cells of distal tubules (dt), including macula densa (md), and glomerulus (gl) are unlabeled (B).
After [3H]estradiol, certain interstitial cells also showed nuclear labeling (not shown here). (Exposure time 12 months. A, X600; B, X800. Stained
with methylene blue/basic fuchsin.)
localization of 1,25-(OH)2-vitamin D3 observed in this study
in cells of the proximal convoluted tubules represents the target
site for this action of the hormone.
The localization of 1,25-(OH)2-vitamin D3 in the nucleus of
podocytes is highly intriguing. The functions of the podocyte
have not been clarified. A largely mechanical role has been
ascribed to its interpedicel filtration slits, but more complex
functions, such as the synthesis of components of the basal
membrane as the main filtration barrier, have also been sug-
gested for the podocyte itself (16). The present finding of nu-
clear localization of 1,25-(OH)2-vitamin D3 in podocytes
suggests a regulatory action of the hormone on functions of
these cells. Mesangial cells do not seem to concentrate radio-
activity in their nuclei under the conditions of the experiment.
Ultrastructural changes have been reported to occur in both
podocytes and mesangial cells during prolonged D3 hypervi-
taminosis and hypercalcemia (17).
Although it has been demonstrated that 1,25-(OH)2-vitamin
D3 can be synthesized only by the kidney (18) and that 25-
(OH)2-vitamin D2 lIa-hydroxylase, required for this synthesis,
is present only in renal mitochondria (19), the exact cellular site
of the production of the hormone has not been established.
Fanconi disease is a condition in which lack of synthesis of
1,25-(OH)2-vitamin D3 coexists with degenerative lesions in
( J~~~~~~~~J
FIG. 4. Autoradiogram of rat kidney 5 min after injection of 3H-labeled parathyroid hormone, showing various concentrations of radioactivity
in the apical portion of epithelial cells of proximal tubules. Cells of collecting duct (left bottom), glomerulus (in center) and distal tubules (to
right of glomerulus) appear unlabeled. (Exposure time 9 months. X600. Stained with methyl green pyronin.)
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proximal convoluted tubules (2). This suggests the possibility
of these tubules being the site of synthesis of 1,25-(OH)2-vitamin
D3. This is further supported by the results of experiments in
which radioactivity was found to be restricted to the proximal
part of the nephron, after the administration of 14C-labeled
vitamin D (2), because cytoplasmic radioactivity can be ex-
pected to be higher in cells that metabolize steroid hormones
when compared to other cells, after injection of radioactively
labeled precursors.
The synthesis of 1,25-(OH)2-vitamin D3 is known to be reg-
ulated by various hormones. The identification of the target
cells for these hormones in the kidney would help in establishing
the site of synthesis of 1,25-(OH)2-vitamin D3. It has been shown
that in birds, and probably also in mammals (20), estrogens
stimulate the synthesis of 1,25-(OH)2-vitamin D3. The dem-
onstration that estradiol localizes in nuclei of proximal tubules
points again to these tubules as the probable site of synthesis of
1,25-(OH)2-vitamin D3. This is further supported by the lo-
calization in the cells of proximal convoluted tubules of para-
thyroid hormone, which has been shown to play a role in the
regulation of 1,25-(OH)2-vitamin D3 synthesis (1, 20). The
cellular localization of parathyroid hormone deserves, however,
further discussion. Nordquist and Palmieri (21) found that
131I-labeled parathyroid hormone injected intravenously could
be localized in mitochondria located at the basal end of epi-
thelial cells of proximal convoluted tubules. Maunsbach (22)
indicated that Nordquist and Palmieri's observation was not
consistent with the results of numerous studies showing that
polypeptides and proteins of low molecular weight are resorbed
by the proximal convoluted tubules by endocytosis and can be
localized at the apical end of these cells. Our present observa-
tions agree with those of Nordquist and Palmieri (21) in local-
izing the hormone in the proximal part of proximal convoluted
tubules but show that, 5 and 10 min after the injections, the
hormone is concentrated in the apical region of the cells, where
endocytosis occurs. Although preinjected unlabeled parathyroid
hormone prevents uptake of radioactivity in proximal tubules
after injection of radioactively labeled parathyroid hormone
(21), which suggests specificity of uptake, this does not exclude
that there are other sites of action for this hormone in the
kidney.
According to the results of the autoradiographic studies, in
conjunction with other evidence, it appears that in the kidney
the site of action of 1,25-(OH)2-vitamin D3 on calcium ab-
sorption and the site of synthesis of the hormone itself are
anatomically distinct. This conclusion is based on the strong
nuclear localization of 1,25-(OH)2-vitamin D3 in the distal
portion of the tubules, including pars convoluta, macula densa,
and pars recta; in comparison, estradiol and parathyroid hor-
mone, both known to stimulate the synthesis of 1,25-(OH)2-
vitamin D3, concentrate in cells of proximal tubules, the ex-
pected site of manufacture of the hormone.
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